Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares are gaining significantly traction in the pre-market session today, following the release of promising interim data from its ongoing
Pasithea Therapeutics Corp. (KTTA), a biotechnology company, has gained an increase of 3.29% in the aftermarket trading session. As a result, KTTA stock is trading at
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.